Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $43.52 Analyst target: $84.13 Upside: 93.31%
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
See the full interactive analysis & chart →Informational only — not investment advice.